Optical coherence tomography (OCT) is a three-dimensional optical imaging technique that has been successfully implemented in ophthalmology for imaging the human retina, and in studying animal models of disease. OCT can nondestructively visualize structural features in tissue at cellular-level resolution, and can exploit contrast agents to achieve molecular contrast. Photothermal OCT relies on the heat-producing capabilities of antibody-conjugated gold nanoparticles to achieve molecular contrast. A pump laser at the nanoparticle resonance wavelength is used to heat the nanoparticles in the sample, and the resulting changes in the index of refraction around the nanoparticles are detected by phase-sensitive OCT. Lock-in detection of the pump beam amplitude-modulated frequency and the detector frequency allow for highsensitivity images of molecular targets. This approach is attractive for nondestructive three-dimensional molecular imaging deep (approximately 2 mm) within biological samples. The protocols described here achieve a sensitivity of 14 parts per million (weight/weight) nanoparticles in the sample, which is suf fi cient to differentiate EGFR (epidermal growth factor receptor)-overexpressing cells from minimally expressing cells in three-dimensional cell constructs.
Introduction
Molecular imaging is a powerful tool for investigating biological signaling, disease processes, and potential therapies in both in vivo and in vitro systems. Microscopy, including confocal and multiphoton microscopy, has been the standard for high-resolution molecular imaging in live cells and tissues. However, these microscopy techniques suffer from relatively shallow imaging depths. MRI and PET have been the standard for functional imaging deep within the body, with the caveat of relatively poor resolution. Optical coherence tomography (OCT) fi lls a niche between high-resolution microscopy techniques and whole-body imaging techniques with relatively good resolution (~1-10 μ m) and penetration depths (~1-2 mm) in tissue. Molecular imaging in this regime would be a powerful tool for scientists and clinicians. Two examples with potentially high impact are imaging the effects of antiangiogenic treatment in age-related macular degeneration, and whole-tumor imaging of molecular microenvironments.
OCT is intrinsically insensitive to incoherent scattering processes such as fl uorescence and spontaneous Raman scattering, which are central to optical molecular imaging, because OCT depends on coherent detection of scattered light. Gold nanoparticles are attractive contrast agents for OCT because they are biocompatible, do not exhibit photobleaching or cytotoxicity, and are tunable through a broad range of wavelengths including the visible and near-infrared regions. Gold nanoparticles currently under development for molecular contrast OCT include highly scattering gold nanoshells [ 1 ] , gold nanocages [ 2 ] , and gold nanorods [ 3 ] . Gold nanoshells are also under development as photothermal contrast agents [ 4 ] .
Photothermal imaging [5] [6] [7] provides one potential method for increasing the molecular contrast of OCT over a highly scattering background. In photothermal imaging, strong optical absorption of a small metal particle at its plasmon resonance results in a change in temperature around the particle (photothermal effect). This temperature change leads to a variation in the local index of refraction that can be optically detected with an amplitude-modulated heating beam that spatially overlaps with the focus position of the sample arm of an interferometer. Previous work has shown that photothermal interference contrast images of gold nanoparticles from a modi fi ed DIC microscope are insensitive to a highly scattering background [ 5 ] . We have applied this concept to OCT with the added bene fi ts of depth resolution and increased imaging depth. Our photothermal OCT system has a measured sensitivity of 14 parts per million (ppm, weight/weight), and we have used this system to measure epidermal growth factor receptor (EGFR) expression from live monolayers of cells and in three-dimensional tissue constructs [ 8 ] . Protocols for nanoparticle conjugation, labeling of cell monolayers and three-dimensional cell constructs, dark-fi eld microspectral imaging, and photothermal OCT imaging follow.
Materials
1. Cells that overexpress EGFR (MDA-MB-468) [ 9 ] and cells that express low levels of EGFR (MDA-MB-435) [ 10 ] were obtained from the American Type Culture Collection (ATCC).
2. Dulbecco's Modi fi ed Eagle's Medium (DMEM) (Gibco/BRL, Bethesda, MD) supplemented with 10 % fetal bovine serum (FBS, HyClone, Ogden, UT).
Cell Culture
1. Dark-fi eld microspectroscopy system [ 11, 12 ] . (e) Custom spectrometer with 1,024 pixel line-scan CCD camera (ATMEL, Aviiva).
(f) Software to control lateral scanning, perform data acquisition, rescaling from wavelength to wavenumber, Fourier Transform, two-dimensional B-scan display, and data archiving in real time (Bioptigen Inc.).
(g) Optical chopper to amplitude-modulate the heating laser (Thorlabs). 6. At the end of the interaction period, centrifuge the solution at 2245 × g until a pellet is formed (~10 min) ( see Note 5) .
Methods
7. Withdraw the supernatant and resuspend the nanoparticle pellet in 1 mL of phosphate buffered saline ( see Note 6 ).
1. Suspend 80,000 cells in 1 mL of media, plate onto 2.0 mL chambered cover glasses, and incubate for 12-16 h to allow for cell adhesion.
2. Exchange media with a mixture of 0.5 mL antibody-conjugated nanosphere suspension (2.35 × 10 10 nanospheres/mL; see Note 7 ) and 0.5 mL fresh media. 4. Image labeled monolayers using dark-fi eld microspectroscopy and photothermal OCT ( see Note 9 and Fig. 1 ).
1. Acquire color images of cells to con fi rm spatial distribution nanoparticle labeling.
2. Acquire dark-fi eld scattering spectra from the labeled cells to con fi rm plasmon resonance peak of the functionalized nanoparticles.
1. Acquire multiple OCT depth scans (A-scans) at each position in the sample.
2. Calculate the photothermal signal at each point in the crosssectional image.
(a) Take the Fourier transform of the phase vs. time at each point in the image.
(b) The photothermal signal is the peak at the pump laser frequency, minus the background (Fig. 2 ).
1. Mix 3 % low-gelling point agarose with a cell suspension in media (100 × 10 6 cells/mL) to obtain a homogeneous cell distribution.
2. Pour agarose/cell/media mixture into 24-well inserts at 2-3 mm thickness for gelation at room temperature ( see Note 10 ).
Cell Monolayer Experiments

Dark-Field Microspectroscopy
Photothermal OCT Imaging
ThreeDimensional Tissue Culture
Fig. 1 EGFR expression and nanoparticle labeling was con fi rmed in EGFR+/nanosphere+ cells ( a -d ), with two control groups that include EGFR−/nanosphere+ ( e -h
) and EGFR+/nanosphere− ( i -l ) using dark-fi eld microscopy ( panels a , e , i ) and microspectroscopy ( panels b , f , j ). The phase as a function of time in the photothermal system is plotted for the experimental ( panel c ) and control groups ( panels g , k ), and the Fourier transform of the phase con fi rms oscillations at 25 Hz (the pump laser modulation frequency) ( panels d , h , l ). In three repeated experiments, the photothermal signal from overexpressing cell monolayers was at least 9 dB higher than the highest signal from the cells that express low levels of EGFR. The repeated experiments were performed at pump powers of 7.5-8.5 kW/cm ) with 84 ppm nanospheres and 25 Hz pump frequency ( a ). The de fi nition of the photothermal signal ( b ) in the Fourier-transformed phase is the peak at 25 Hz ( arrow 1 , the pump beam modulation frequency in these experiments) minus the background ( arrow 2 , 27-50 Hz). Reproduced with permission from ref. [ 8 ] 3. After gelation, topically label cell constructs with antibodyconjugated nanospheres in the same manner as the monolayer experiment ( see Subheading 3.1 ), except add 10 % DMSO to the antibody-conjugated nanosphere suspension to allow the solution to penetrate the three-dimensional construct, and incubate for 30 min [ 10 ] .
4. Wash construct two times with saline.
5. Place a coverslip on the construct for photothermal OCT imaging.
6. Photothermal OCT imaging parameters included 1,000 sequential A-scans (1 ms integration time for each A-scan) at each of 110 lateral positions across the top of the construct (1 mm scan length in the lateral dimension). See Fig. 3 . 
Notes
1. Commercial spectral domain OCT systems can be purchased from a variety of sources (Thorlabs, Bioptigen, Inc., etc.), and may be used with the heating laser and chopper to perform photothermal OCT measurements.
2. The pump laser wavelength must overlap with the resonance peak of the nanoparticle of interest, and must provide suf fi cient power to produce a measurable photothermal signal. In these experiments, 20 mW of 532 nm light was incident on the sample. 4. Verify antibody attachment by removing 200 μ L of the resulting conjugated colloid and mix with 10 μ L of 10 % NaCl. It is well known that the addition of NaCl will cause nanoparticle aggregation [ 15 ] , resulting in a color change to the solution, unless the nanoparticle surface has been well coated.
5. Centrifugation step can be repeated if necessary to form a pellet.
6. Resuspend in 0.5 mL of phosphate buffered saline twice to ensure complete removal of the excess PEG.
7. The antibody-conjugated nanosphere suspension of 2.35 × 10 10 nanospheres/mL corresponds to 1.3 optical density in a 1 cm path-length cuvette.
8. For photothermal OCT imaging of cell monolayers, replace the media (which contains phenol red that could interfere with the photothermal experiments) with saline.
9. Con fi rm viability of cells after photothermal imaging using trypan blue exclusion. Our previous experiments show no loss of cell viability due to photothermal imaging.
10. The viability of the cells in the three-dimensional construct can be veri fi ed by applying a live-dead fl uorescence stain (Invitrogen) without nanosphere labeling. Confocal microscopy can be used to quantify the ratio of live (green fl uorescence) to dead (red fl uorescence) cells.
